<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131314">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01392508</url>
  </required_header>
  <id_info>
    <org_study_id>PEP-FMHBP-001</org_study_id>
    <nct_id>NCT01392508</nct_id>
  </id_info>
  <brief_title>IMproved PREdiction of Severe Sepsis in the Emergency Department</brief_title>
  <acronym>IMPRESSED</acronym>
  <official_title>Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Axis Shield Diagnostics Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Axis Shield Diagnostics Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used
      as a marker of severe sepsis (including septic shock) in patients presenting to the
      emergency department with suspected infection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">759</enrollment>
  <condition>Systemic Inflammatory Response Syndrome (SIRS)</condition>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma (LiHep and citrate)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to emergency department with suspected infection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Greater than or equal to 18 years

          -  Suspected Infection

          -  one or more SIRS criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Linder</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skanes Universitetssjukhus I Lund, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magnus Paulsson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skanes universitetssjukhuset i Malmo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrik Nyberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitetssjukhuset i Linkoping</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Lange-Jendeberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitetssjukhuset i Orebro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ryan Arnold</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cooper Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset i Linkoping</name>
      <address>
        <city>Linkoping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skanes Universitetssjukhus i Lund</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skanes Universitetssjukhuset i Malmo</name>
      <address>
        <city>Malmo</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset i Orebro</name>
      <address>
        <city>Orebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <lastchanged_date>September 1, 2015</lastchanged_date>
  <firstreceived_date>July 11, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
